2. Department of Virology II

Kusunoki S, Takahashi T, Oishi K, Tanaka-Taya K
Acute Flaccid Myelitis Collaborative Study I.

1)Aghamohammadi A, Abolhassani H, Kutukculer N,

ClinicalWassilak SG, Pallansch MA, Kluglein S, Quinn J,

Temporally Associated With an Enterovirus D68

Sutter RW, Wang X, Sanal O, Latysheva T,

Outbreak: Results of a Nationwide Survey of Acute

Ikinciogullari A, Bernatowska E, Tuzankina IA,

Flaccid Paralysis in Japan, August-December 2015.

Costa-Carvalho

BT,FrancoJL,

Clin Infect Dis 66: 653-664, 2018

Karakoc-Aydiner

E,

Singh

S,

SomechR,

BezrodnikL,
5)

Espinosa-Rosales FJ, Shcherbina A, Lau YL,

Myelitis

Doan YH, Suzuki Y, Fujii Y, Haga K, Fujimoto A,

unusual G9P[4] rotavirus strains in India between

Primary Immunodeficiencies Are a Reservoir of2011 and 2013. Infect Genet Evol. 2017, 54: 417-428

Poliovirus and a Risk to Polio Eradication. Frontiers
6)

Fukuhara T, Tamura T, Ono C, Shiokawa M, Mori H,

as one of the JMF Centers Network Investigators andUemura K, Yamamoto S, Kurihara T, Okamoto T,

Study Collaborators]

Suzuki R, Yoshii K, Kurosu T, Igarashi M, Aoki H,
Sakoda Y, Matsuura Y. Host-derived apolipoproteins

Akagami M, Ito M, Niira K, Kuroda M, Masuda T,

play comparable roles with viral secretory proteins

Haga K, Tsuchiaka S, Naoi T, Kishimoto M, Sano

Erns and NS1 in the infectious particle formation ofK, Omatsu T, Aoki H, Katayama Y, Oba M, Oka T,
Ichimaru T,

Yamasato H,

Ouchi Y,

Katayama K,

Mizutani T,

Nagai M. Complete

Flaviviridae. PLoS Pathog. e1006475. (2017)

Shirai J,
7)

Fukushima S., Kiyohara T., Ishii K., Nakano T. andgenome analysis of porcine kobuviruses from theHamada A. Immunogenicity of aluminum-adsorbed

feces of pigs in Japan Virus Genes, 2017 Aug; 53:

hepatitis A vaccine (Havrix®) administered as a593-602

third

M,

Lemon

SM,

after

primary dosesofJapanese

for Japanese travelers to endemic countries. Vaccine

Lindenbach

35: 6412-6415 (2017)

BD,Lohmann V, Moradpour D, Pietschmann
T, Rice CM, Thimme R, Wakita T. Criticaldose

aluminum-free hepatitis A vaccine (Aimmugen®)

Bartenschlager R, Baumert TF, Bukh J,
Houghton

4)

Flaccid

Katayama K: Complex reassortment events ofBarbouche MR, McKinlay MA. Patients with

3)

Acute

A, Imamura D, Shinoda S, Chawla-Sarkar M,

Network Investigators and Study Collaborators,

2)ofTakai-Todaka R, Someya Y, Nayak MK, Mukherjee

Nonoyama S, Modell F, Modell V, the JMF Centersin immunology 8: 685, 2017 [Shimizu H, contributed

Features8)

Hansen MD, Johnsen IB, Stiberg KA, Sherstova T,

challenges and emerging opportunities in

Wakita T, Richard GM, Kandasamy RK, Meurs EF,

hepatitis C virus research in an era of potent

Anthonsen MW. Hepatitis C virus triggers Golgi

antiviralfragmentation

therapy:

Considerations

for

and

autophagythroughthescientists and funding agencies.Virus Res.

immunity-related GTPase M. Proc Natl Acad Sci U S

2018 Mar 15;248:53-62

A. 2017 Apr 25;114(17):E3462-E3471

Chong PF, Kira R, Mori H, Okumura A, Torisu H,
Yasumoto S, Shimizu H, Fujimoto T, Hanaoka N,

9)Hasegawa K, Yuichi Someya, Hideki Shigematsu,
Tomomi

Kimura-Someya,

Takashi

Kumasaka

Crystallization and preliminary X-ray analysis of

Aizaki H, Ohtani N, Sureau C, Wakita T, Osada H,

23-nm virus-like particles from norovirus Chiba

Watashi K. Chemical array system, a platform tostrain. Acta Crystallography, F73, 568-573, 2017

identify novel hepatitis B virus entry inhibitors

10) Huimin Bai, Ling Fang, Michiyo Kataoka, Naokazu
Takeda,TakajiWakitaand

Tian-Cheng

Li*

targetingsodiumtaurocholate

cotransporting

polypeptide. Sci Rep. 8(1):2769. (2018)

Characterization of Porcine Sapelovirus Isolated15) Kato M, Hamada-Tsutsumi S, Okuse C, Sakai A,

from Japanese Swine with PLC/PR。F/5 Cells.

Matsumoto N, Sato M, Sato T, Arito M, Omoteyama

TransboundK, Suematsu N, Okamoto K, Kato T, Itoh F, Sumazaki

Emerg

Dis.

2017

Dec

28.

doi:

10.1111/tbed.12796

R,11) Ito M, Suns, Fukuhara T, Suzuki R, Tamai M,
Yamauchi T, Nakashima K, Tagawa Y, Okazaki S,
Matsuura Y, Wakita T, Suzuki T. Development of
hepatoma-derived, bidirectional oval-like cells as amodel to study host interactions with hepatitis C
virus

duringdifferentiation.

Oncotarget.

33:53899-53915. (2017)

TanakaRyo A, Ohtani N, Tanaka Y, Mizokami M, Wakita T,
Guo H, Watashi K. Functional association of cellular
microtubules with viral capsid assembly supports

Yotsuyanagi

H,

Kato

T,

Kurokawa-Suzuki M. Effects of vaccine-acquired
polyclonal anti-HBs antibodies on the prevention of
HBV

infection

Gastroenterol.

of
doi:

non -vaccine

genotypes.

J

10.1007/s00535-017-1316-3,

201716) Hasegawa K, Yuichi Someya, Hideki Shigematsu,
Tomomi12) Iwamoto M, Cai D, Sugiyama M, Suzuki R, Aizaki H,

Y,Kimura-Someya,

Takashi

Kumasaka

Crystallization and preliminary X-ray analysis of
23-nm virus-like particles from norovirus Chiba
strain. Acta Crystallography, F73, 568-573, 201717) Kitamura K, Que L, Shimadu M, Koura M, Ishihara

efficient hepatitis B virus replication. Sci Rep 7:Y, Wakae

10620 (2017)

T, Muramatsu M. Flap endonuclease 1 is involved in13) Kai Y, Hikita H, Morishita N, Murai K, Nakabori T,
Iio S, Hagiwara H, Imai Y, Tamura S, Tsutsui S, Naito

K, Nakamura

T, Watashi

K, Wakita

cccDNA formation in the hepatitis B virus.

PLoS

Pathog. 2018 Jun 21;14(6):e1007124

M, Nishiuchi M, Kondo Y, Kato T, Suemizu H,18) Koizumi Y, Ohashi H, Nakajima S, Tanaka Y, Wakita

Yamada R, Oze T, Yakushijin T, Hiramatsu N,

T, Perelson AS, Iwami S, Watashi K. Quantifying

Sakamori R, Tatsumi T, Takehara T. Baseline

antiviral activity optimizes drug combinations against

quasispecies selection and novel mutations contributehepatitis C virus infection. Proc Natl Acad Sci USA

to emerging resistance-associated substitutions in

114: 1922-1927 (2017)

hepatitis
treatment.

C

virus

after

Sci

Rep.

direct -acting
7:

41660.

antiviraldoi:

10.1038/srep41660, 201719) Kondo K, Tsugawa T, Ono M, Ohara T, Fujibayashi S,
Tahara Y, Kubo N, Nakata S, Higashidate Y, Fujii Y,
Katayama K, Yoto Y, Tsutsumi H: Clinical and14) Kaneko M, Futamura Y, Tsukuda S, Kondoh Y, Sekine

Molecular Characterization of the 2014 G8P[8]T, Hirano H, Fukano K, Ohashi H, Saso W, Morishita

Rotavirus Outbreak in Japan. Emerg Infect Dis. 2017,

R, Matsunaga S, Kawai F, Ryo A, Park SY, Suzuki R,

23(6):968-972

20) Kuroda M, Masuda T, Ito M, Naoi Y, Doan YH,

26) Li TC., Yoshizaki S., Kataoka M., Ami Y., Suzaki Y.,

Haga K, Tsuchiaka S, Kishimoto M, Sano K,Omatsu

Doan Y.H., Haga K., Ishii K., Takeda N. and Wakita T.

T, Katayama Y, Oba M, Aoki H, Ichimaru T, Sunaga

Genetic and physicochemical analyses of a novel

F, MukonoI, Yamasato H, Shirai J, Katayama K,

ferret hepatitis E virus, and clinical signs of infection

Mizutani T, Oka T, Nagai M. Genetic diversity andafter birth. Infection, Genetics and Evolution 25;

intergenogroup recombination events of sapoviruses

153-159 (2017)detected from feces of pigs in Japan Infection,
Genetics and Evolution, 2017 Nov; 55: 209-217

27) Loo TM, Kamachi F, Watanabe Y, Yoshimoto S,
Kanda H, Arai Y, Nakajima-Takagi Y, Iwama A, Koga

21) Kuroda M, Masuda T, Ito M, Naoi Y, Doan YH, Haga

T, Sugimoto Y, Ozawa T, Nakamura M, Kumagai M,

K, Tsuchiaka S, Kishimoto M,Sano K, Omatsu T,

Watashi K, Taketo MM, Aoki T, Narumiya S, Oshima

Katayama Y, Oba M, Aoki H, Ichimaru T, Sunaga F,

M, Arita M, Hara E, Ohtani N. Gut microbiota

Mukono I, Yamasato H, Shirai J, Katayama K,

promotes obesity-associated liver cancer throughMizutani T, Oka T, Nagai M. Genetic diversity andPGE2-mediated suppression of antitumor immunity.

intergenogroup recombination events of sapoviruses

Cancer Discov 7: 522-538 (2017)detected from feces of pigs in Japan. Infect Genet
Evol 55: 209-217, 201728) Mizukoshi F, Nagasawa K, Doan YH, Haga K,
Yoshizumi S, Ueki Y, Shinohara Ishikawa M, Sakon

22) Li TC, Yoshizaki S, Ami Y, Suzaki Y, Johne R, Wakita

N, Shigemoto N, Okamoto-Nakagawa R, Ochi A,

T. No evidence of rat hepatitis E virus excretion into

Murakami K, Ryo A, Suzuki Y, Katayama K, Kimura

urine of rats. Jpn J Infect Dis. 70: 305-307 (2017)

H. Molecular Evolution of the RNA-Dependent RNA

23) Li TC, Yoshizaki S, Kataoka M, Ami Y, Suzaki Y,
Doan YH, Haga K, Ishii K, Takeda N, Wakita T.
Genetic and physicochemical analyses of a novel
ferret hepatitis E virus, and clinical signs of infection
after birth. Infect Genet Evol 51:153-159, 2017

Polymerase and Capsid Genes of Human Norovirus
Genotype GII.2 in Japan during 2004-2015. Front
Microbiol. 8:705, 201729) Murayama A, Sugiyama N, Suzuki R, Moriyama M.
Nakamura M, Mochizuki H, Wakita T, Kato T. Amino
Acid Mutations in the NS4A Region of Hepatitis C24) Li TC, Yoshizaki S, Kataoka M, Doan YH, Ami Y,

Virus Contribute to Viral Replication and Infectious

Suzaki Y, Nakamura T, Takeda N, Wakita T.

Virus

Determination of Ferret Enteric Coronavirus Genome

doi:10.1128/JVI.02124-16, 2017

inLaboratory Ferrets.

Emerg Infect

Dis

23:

1568-1570, 201725) Li TC, Yoshizaki S, Zhou X, Sentsui H, Shirato K,
Matsuyama S, Melaku SK, Bazartseren B, Takeda N,
Wakita T. Serological evidence of hepatitis E virus
infection in dromedary camels in Ethiopia. J Virol
Methods. 246: 34-37 (2017)

Production.

J

Virol.

91.

30) Noguchi A, Ito H, Miura S, Fujii Y, Katayama K,
Nakagomi T, Nakagomi O, Takahashi T. Regionalvariations

in

the

incidenceofrotavirus

hospitalizations between children living in defined
regions of Akita and Kyoto prefectures, Japan. Japan.
Jpn J Infect Dis. 2017, 70(2):167-170
31) Ogura N, Ogawa K, Watashi K, Ito T, Wakita T. Novel
stable

HBV

producing

cell

line

systemsforexpression and screening antiviral inhibitor ofhepatitis B virus in human hepatoma cell line.

Characterization

Biochem Biophys Res Commun. 498(1):64-71 (2018)

propagation of HCV. PLoS Pathog. 2017 May

32) Ohashi H, Koizumi Y, Fukano K, Wakita T, PerelsonofmiR -122-independent

11;13(5):e1006374

AS, Iwami S, Watashi K. Reply to Padmanabhan and

39) Pham NTK, Thongprachum A, Baba T, Okitsu S,

Dixit: Hepatitis C virus entry inhibitors for optimally

Trinh QD , Komine-Aizawa S, Shimizu H, Hayakawa

boosting direct-acting antiviral-based treatments.

S, Ushijima H. A 3-month-old child of acute

Proc Natl Acad Sci USA 114: E4527-E4529 (2017)

gastroenteritis with enterovirus D68 detected from33) Ohba M, Oka

T, AndoT, Arahata

S, Ikegaya

stool specimen. Clin. Lab 63: 1269-1272, 2017

A, Takagi H, Ogo N, Zhu C, Owada K, Kawamori

40) Pham NTK, Thongprachum A, Trinh QD, Okitsu S,

F, Wang Q, Saif LJ, Asai A Antiviral effect ofKomine-Aizawa S, Shimizu H, Hayakawa S Ushijima

theaflavins against caliciviruses. The Journal ofH.

Antibiotics (2017) 70, 443–447

enterovirus strains circulating among children with34) Oka T, DoanYH, Haga

K, MoriK, Ogawa

T, Yamazaki A. Genetic characterization of rare

Detection

andgenetic

characterizationof

acute gastroenteritis in Japan during 2014-2016.
Infect Genet Evol 61: 16-19, 2018

genotype GII.5 sapovirus strain detected from41) Que L, Liu G, Kitamura K, Wakae K, Li Y, Nishitsuji

food-borne suspected gastroenteritis outbreak among

H, Ujino S, Shimotohno K, Muramatsu M. Molecular

adults in Japan, 2010. Jpn J Infect Dis. 2017; 70:

characterizationof

AID-mediatedreduction

223-224of hepatitis B

virus

transcripts.

Virology.

35) Oka T, Doan YH, Shimoike T, Haga K, Takizawa

2017;510:281-288

K.First complete genome sequences of genogroup V、

42) Ruchusatsawat K., Wongpiyabovorn J., Kawidam C.,

genotype 3 porcine sapoviruses: common 5'-terminal

Thiemsing L., Sangkitporn S., Yoshizaki S., Tatsumi

genomic feature of sapoviruses Virus Genes, 2017

M., Takeda N. and Ishii K. An Outbreak of Acute

Dec; 53: 848-855

Hepatitis Caused by Genotype IB Hepatitis A Viruses36) Oka T, Iritani N, Okada M, Ogawa T, Iizuka S,
Tatsumi C, Harada S, Haga K, Doan YH. First

Contaminating the Water Supply in Thailand.
Intervirology 59: 197-203 (2017)

Complete Genome Sequences of Human Sapovirus43) Sakurai F, Kunito T, Takayama K, Hashimoto R,

Strains Classified as GI.3, GI.4, GI.6,GI.7, andTachibana M, Sakamoto N, Wakita T, Mizuguchi H.

GII.7.Genome Announc. 2018 Mar 22;6(12). pii:Hepatitis C virus-induced innate immune responses in

e00168-18

human iPS cell-derived hepatocyte-like cells. Virus

37) Oka T, Stoltzfus GT, Zhu C, Jung K, Wang Q, Saif

Res. 2017 Sep 9;242:7-15.

LJ. Attempts to grow human noroviruses, a sapovirus,

44) Sakurai F, Mitani S, Yamamoto T, Takayama K,

and a bovine norovirus in vitro. PLoS One, 2018

Tachibana M, Watashi K, Wakita T, Iijima S, Tanaka

Feb;13(2):e0178157

Y, Mizuguchi H. Human induced-pluripotent stem38) Ono C, Fukuhara T, Motooka D, Nakamura S,

cell-derived hepatocyte-like cells as an in vitro model

Okuzaki D, Yamamoto S, Tamura T, Mori H, Sato A,

of human hepatitis B virus infection. Sci Rep 7: 45698

Uemura K, Fauzyah Y, Kurihara T, Suda T, Nishio A,(2017)

Hmwe SS, Okamoto T, Tatsumi T, Takehara T,
Chayama K, Wakita T, Koike K, Matsuura Y.

45) Sato

H, Yokoyama

T, Katayama

K, Takeda

M, Nakamura
N, NodaH, OkaM, TanakaT, Motomura K. Evolutionary Constraints on theintraepithelial

Norovirus Pandemic Variant GII.4_2006b over the

progression Am J Reprod Immunol. 2017 Oct;78(4)Five-Year

PersistenceinJapan.

Front

Microbiol. 2017 13;8:410

neoplasia

along

with

disease52) Thongprachum A, Khamrin P, Thi Kim Pham N,
Takanashi S, Okitsu S, Shimizu H, Maneekarn N,46) Scott T, Moyo B, Nicholson S, Maepa MB, Watashi

Hayakawa S Ushijima H. Multiplex RT-PCR for rapid

K, Ely A, Weinberg MS, Arbuthnot P. ssAAVs

detection of viruses commonly causing diarrhea incontaining cassettes encoding SaCas9 and guides

pediatric patients. J Med Virol 89: 818-824, 2017targeting hepatitis B virus inactivate replication of the53) Tsukuda S, Watashi K, Hojima T, Isogawa M,

virus in cultured cells. Sci Rep 7: 7401 (2017)

Iwamoto M, Omagari K, Suzuki R, Aizaki H, Kojima47) Seishima N, Kondo S, Wakae K, Wakisaka N,

S, Sugiyama M, Saito A, Tanaka Y, Mizokami M,

Kobayashi E, Kano M, Moriyama-Kita M, Nakanishi

Sureau C, Wakita T. A new class of hepatitis B and D

Y, Endo K, Imoto T, Ishikawa K, Sugimoto H, Hatano

virus entry inhibitors, proanthocyanidin and its

M, Ueno T, Koura M, Kitamura K, Muramatsu M,

analogs, that directly act on the viral large surface

Yoshizaki T.Expression and subcellular localisation

proteins. Hepatology 65: 1104-1116 (2017)of AID and APOBEC3 in adenoid and palatine
tonsils. Sci Rep. 2018 Jan 17;8(1):918

54) Utsumi T, Lusida MI, Dinana Z, Wahyuni RM,
Yamani LN, Juniastuti, Soetjipto, Matsui C, Deng L,48) Shimura S, Watashi K, Fukano K, Peel M, Sluder A,

Abe T, Doan YH, Fujii Y, Kimura H, Katayama K,

Kawai F, Iwamoto M, Tsukuda S, Takeuchi JS,

Shoji I: Occurrence of norovirus infection in an

Miyake T, Sugiyama M, Ogasawara Y, Park SY,

asymptomatic population in Indonesia. Infect Genet

Tanaka Y, Kusuhara H, Mizokami M, Sureau C,

Evol. 2017, 55:1-7

Wakita T. Cyclosporin derivatives inhibit hepatitis B

55) Utsumi T, Wahyuni RM, Doan YH, Dinana Z,

virus entry without interfering the NTCP transporter.

Soegijanto S, Fujii Y, Juniastuti, Yamani LN, Matsui

J Hepatol 66: 685-692 (2017)

C, Deng L, Abe T, Soetjipto, Lusida MI, Ishii K,49) Sugiyama R, Murayama A, Nitta S, Yamada N,

Shimizu H, Katayama K Shoji I. Equine-like G3

Tasaka-Fujita M, Masaki T, Aly HH, Shiina M, Ryo A,

rotavirus strains as predominant strains amongIshii

children in Indonesia in 2015-2016. Infect Genet Evol

K,

Wakita

T,

Kato

T.

Interferon

sensitivity-determining region of hepatitis C virus
influences virus production and interferon signaling.
Oncotarget. 2017 21;9(5):5627-5640

61: 224-228, 201856) Wang W, Wang Y, Qu C, Wang S, Zhou J, Cao W, Xu
L, Ma B, Hakim MS, Yin Y, Li TC, Peppelenbosch50) Sun S, Nakashima K, Ito M, Li Y, Chida T, Takahashi

MP, Zhao J, Pan Q. The RNA genome of hepatitis E

H, Watashi K, Sawasaki T, Wakita T, Suzuki T.

virus

robustly triggers

anantiviralinterferon

Involvement of PUF60 in Transcriptional andresponse. Hepatology. 2018 67(6): 2096-2112. doi:

Post-transcriptional Regulation of Hepatitis B Virus

10.1002/hep.29702

Penomic RNA Expression. Sci Rep 7: 12874 (2017)57) Watanabe R, Mizoguchi H, Oikawa H, Ohashi H,51) Iizuka T, Kousho Wakae, Mitsuhiro Nakamura,

Watashi K, Oguri H. Stereo-controlled synthesis ofKoichi Kitamura, Masanori Ono, Hiroshi Fujiwara,functionalized tetrahydropyridines based on theandcyanomethylation

Masamichi

Muramatsu

APOBEC3G

isincreasingly expressed on the human uterine cervicalof

1,6-dihydropyridines

andgeneration of anti-hepatitis C virus agents. Bioorg

potency tests of Sabin-derived inactivated polio

Med Chem 25: 2851-2855 (2017)vaccines. Biologicals, 52, 12-17, 201858) Yamada N, Sugiyama R, Nitta S, Murayama A,64) Arita M., Dobrikov G., Pürstinger G., Galabov AS.

Kobayashi M, Okuse C, Suzuki M, Yasuda K,

Allosteric regulation of phosphatidylinositol 4-kinase

Yotsuyanagi H, Moriya K, Koike K, Wakita T, Kato T.

III beta by an anti-picornavirus compound MDL-860.

ResistanceACS Infectious Diseases, 3: 585-594, 2017

mutationsof hepatitis B

virus inentecavir-refractory patients. Hepatol Comm. 1:
110-121, 201759) Yamanaka A, Moi ML, Takasaki T, Kurane I, Matsuda
M, Suzuki R, Konishi E. Utility of Japanese
encephalitis

virus

subgenomic

replicon-based

single-round infectious particles as antigens inneutralization tests for Zika virus and three otherflaviviruses. J Virol Methods. 243:164-171. (2017)60) Yao WL, Ikeda S, Tsukamoto Y, Shindo K, Otakaki Y,
Qin M, Iwasawa Y, Takeuchi F, Kaname Y, Chou YC,
Chang C, Watashi K, Wakita T, Noda T, Kato H,
Fujita T. Establishment of a human hepatocellular cellline capable of maintaining long-term replication ofhepatitis B virus. Int Immunol 29: 109-120 (2017)61) Yasumoto J, Kasai1 H, Yoshimura K, Otoguro T,
Watashi K, Wakita T, Yamashita A, Tanaka T, Takeda
S, Moriishi K. Hepatitis B virus prevents excessive
viral production via reduction of cell-death inducing
DFF45-like effectors. J Gen Virol 98: 1762-1773(2017)
62) Yokoyama M, Oka T, Takagi H, Kojima H, Okabe T,
Nagano T,

Tohya Y,

Sato H. A Proposal for a

Structural Model of the Feline Calicivirus Protease
Bound to the Substrate Peptide under Physiological
Conditions Frontiers in Microbiology,

2017 Jul; 8:138363) Someya Y, Yasushi Ami, Reiko Takai-Todaka, Akira
Fujimoto, Kei Haga, Kosuke Murakami, Yoshiki Fujii,
Haruko Shirato, Tomoichiro Oka, Takashi Shimoike,
Kazuhiko Katayama, and Takaji Wakita. Evaluationof the use of various rat strains for immunogenic